CXCL14 deficiency in mice attenuates obesity and inhibits feeding behavior in a novel environment

PLoS ONE

Volumn 5, Issue 4, 2010, Pages

  Tanegashima, Kosuke ^a   Okamoto, Shiki ^b   Nakayama, Yuki ^a,c   Taya, Choji ^a   Shitara, Hiroshi ^a   Ishii, Rie ^a   Yonekawa, Hiromichi ^a   Minokoshi, Yasuhiko ^b   Hara, Takahiko ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL14 CHEMOKINE; ALPHA CHEMOKINE; CXCL14 PROTEIN, MOUSE; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIRTH RATE; CELL INFILTRATION; CONTROLLED STUDY; DENDRITIC CELL; FEEDING BEHAVIOR; FEMALE; FOOD INTAKE; GENE MUTATION; HETEROZYGOSITY; INSULIN SENSITIVITY; LOCOMOTION; MACROPHAGE; MALE; MOUSE; NONHUMAN; OBESITY; OXYGEN CONSUMPTION; PHENOTYPE; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; SKELETAL MUSCLE; UPREGULATION; WEIGHT CONTROL; ANIMAL; BODY WEIGHT; C57BL MOUSE; DRUG EFFECT; EATING; HYPOTHALAMUS; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; BODY WEIGHT; CHEMOKINES, CXC; EATING; FEEDING BEHAVIOR; FEMALE; HYPOTHALAMUS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; RECOMBINANT PROTEINS;

EID: 77956400185     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010321     Document Type: Article

References (14)

1. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW (2006) Central nervous system control of food intake and body weight. Nature 443: 289-295.
2. Coll AP, Farooqi IS, O'Rahilly S (2007) The hormonal control of food intake. Cell 129: 251-262.
3. Hromas R, Broxmeyer HE, Kim C, Nakshatri H, Christopherson K, 2nd, et al. (1999) Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells. Biochem Biophys Res Commun 255: 703-706.
4. Hara T, Nakayama Y (2009) CXCL14 and insulin action. Vitam Horm 80: 107-23.
5. Meuter S, Schaerli P, Roos RS, Brandau O, Bosl MR, et al. (2007) Murine CXCL14 is dispensable for dendritic cell function and localization within peripheral tissues. Mol Cell Biol 27: 983-992.
6. Nara N, Nakayama Y, Okamoto S, Tamura H, Kiyono M, et al. (2007) Disruption of CXC motif chemokine ligand-14 in mice ameliorates obesity-induced insulin resistance. J Biol Chem 282: 30794-30803.
7. Larson BA, Sinha YN, Vanderlaan WP (1976) Serum growth hormone and prolactin during and after the development of the obese-hyperglycemic syndrome in mice. Endocrinology 98: 139-145.
8. Lu D, Willard D, Patel IR, Kadwell S, Overton L, et al. (1994) Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 371: 799-802.
9. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, et al. (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301: 805-809.
10. Gross C, Zhuang X, Stark K, Ramboz S, Oosting R, et al. (2002) Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 416: 396-400.
11. Huising MO, van der Meulen T, Flik G, Verburg-van Kemenade BM (2004) Three novel carp CXC chemokines are expressed early in ontogeny and at nonimmune sites. Eur J Biochem 271: 4094-4106.
12. Lu M, Grove EA, Miller RJ (2002) Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor. Proc Natl Acad Sci U S A 99: 7090-7095.
13. Bagri A, Gurney T, He X, Zou YR, Littman DR, et al. (2002) The chemokine SDF1 regulates migration of dentate granule cells. Development 129: 4249-4260.
14. Zhu Y, Yu T, Zhang XC, Nagasawa T, Wu JY, et al. (2002) Role of the chemokine SDF-1 as the meningeal attractant for embryonic cerebellar neurons. Nat Neurosci 5: 719-720.